Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115487) titled 'Efficacy and Safety of Endovascular Therapy with Intra-Arterial Thrombolysis for Medium Vessel Occlusion Stroke--the IAT-MeVO Trial' on Dec. 26, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Lschemic Stroke
Intervention:
Endovascular Treatment Group:After enrollment, patients will receive endovascular treatment (EVT) combined with Best drug therapy (BMT). First, arterial thrombolysis was performed using tenecteplase (TNK). If reperfusion (mTICI score >=2b) is not achieved in angiography after 10 minutes of adequate admini...